Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-2,080
Closed -$287K – 356
2021
Q1
$287K Sell
2,080
-1,079
-34% -$157K 0.02% 307
2020
Q4
$412K Buy
3,159
+498
+19% +$55.3K 0.03% 274
2020
Q3
$244K Buy
+2,661
New +$223K 0.02% 284
2020
Q1
– Sell
-4,057
Closed -$385K – 282
2019
Q4
$385K Buy
4,057
+720
+22% +$65.9K 0.02% 260
2019
Q3
$292K Sell
3,337
-278
-8% -$23.2K 0.01% 291
2019
Q2
$292K Buy
+3,615
New +$286K 0.01% 337
2017
Q4
– Sell
-11,006
Closed -$1.08M – 408
2017
Q3
$1.08M Sell
11,006
-1,557
-12% -$147K 0.02% 295
2017
Q2
$1.1M Sell
12,563
-2,603
-17% -$217K 0.02% 306
2017
Q1
$1.22M Buy
+15,166
New +$1.14M 0.02% 309
2014
Q2
– Sell
-1,037
Closed -$70K – 352
2014
Q1
$70K Buy
+1,037
New +$66.2K ﹤0.01% 490

Other funds holding APTV

Advisory Research's APTV Position: Q2 2021 in Review

Advisory Research sold out of Aptiv (APTV) in Q2 2021, closing a stake of 2,080 shares — an estimated $287K sold.

Advisory Research first reported a position in APTV in Q1 2014 and held it in 10 quarters. The position peaked at $1.22M in Q1 2017. 717 funds tracked by Wall St. Rank hold APTV as of Q2 2021.

  • Advisory Research reported no remaining Aptiv position as of Q2 2021 after selling out during the quarter.
  • Advisory Research sold 2,080 Aptiv shares in Q2 2021, an estimated $287K.
  • Advisory Research first reported a position in Aptiv in Q1 2014 and held it in 10 quarters.
  • Advisory Research's Aptiv position peaked at $1.22M in Q1 2017.
  • 717 funds tracked by Wall St. Rank held Aptiv as of Q2 2021.

Based on Advisory Research's 13F filing for Q2 2021, filed 16 Aug 2021.